Non-group C adenoviral vectors
US5837511A · kind A · utility
122Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 1995 |
| Grant date | Nov 17, 1998 |
| Priority date | — |
| Expiry date | Oct 2, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10343
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides replication-deficient non-group C adenoviral vectors. Also provided is a therapeutic method, particularly relating to gene therapy, vaccination, and the like, involving the use of such vectors incorporating a foreign nucleic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.